EZH2 and breast carcinoma: Interestingly, the enhancer of zeste homolog 2 (EZH2), which is the catalytic subunit of polycomb repressive complex 2, has been demonstrated to downregulate gene transcription through trimethylation of histone H3 on lysine 27 [44], while it upregulates NOTCH expression, being crucial in the expansion of the stem pool in breast cancer [45].